Skip to main content
MedPathMedPath Home
Clinical Trials/NCT00177268
NCT00177268
Recruiting
Not Applicable

Peripheral Blood, Urine and Skin Sample Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

University of Pittsburgh1 site in 1 country200 target enrollmentOctober 1, 2004
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsCutaneous T-cell LymphomaSezary SyndromeMycosis FungoidesEczemaAtopic Dermatitis

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cutaneous T-cell Lymphoma
Sponsor
University of Pittsburgh
Enrollment
200
Locations
1
Primary Endpoint
Proteomics of Cutaneous T-cell lymphoma
Status
Recruiting
Last Updated
4 months ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

This is a tissue, urine, and blood banking protocol for cutaneous t-cell lymphoma (CTCL), eczema, and atopic dermatitis patients for current and future research.

Detailed Description

The purpose of this study is to provide a central mechanism for monitoring access to peripheral blood, urine, and skin specimens obtained from CTCL, eczema, and atopic dermatitis patients to monitor: * immunologic assays/flow cytometry * tumor progression/regression * genomic studies * proteomic studies * others germane to the advancement of CTCL treatment

Registry
clinicaltrials.gov
Start Date
October 1, 2004
End Date
January 1, 2032
Last Updated
4 months ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Oleg E. Akilov, MD, PhD

Assistant Professor of Dermatology

University of Pittsburgh

Eligibility Criteria

Inclusion Criteria

  • •18 or older
  • •able and willing to provide informed consent
  • •diagnosed with CTCL
  • •diagnosed with either atopic dermatitis or eczema

Exclusion Criteria

  • •Lack of CTCL, atopic dermatitis, or eczema diagnosis in medical record

Outcomes

Primary Outcomes

Proteomics of Cutaneous T-cell lymphoma

Time Frame: Ongoing

Proteomic variables will be measured in blood and tissue of consented CTCL patients.

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
The Acquisition of Blood and Skin Samples From Normal Volunteers to Support Research Activities on Dermatologic DiseasesHealthy VolunteerDermatologic DiseasesSystemic Diseases
NCT00001505National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)304
Completed
Not Applicable
Collection Of Tissue, Blood, and Other Specimens From Patients With Head and Neck Tumors To Study the Causes, Diagnosis, Prevention and Treatment of CancersHead and Neck Cancers
NCT00580203Memorial Sloan Kettering Cancer Center1,468
Active, not recruiting
Not Applicable
Spontaneous Regression in Metastatic Melanoma and Renal Cell CarcinomaMelanoma; Renal Cell Carcinoma
NCT03728842Indiana University19
Completed
Not Applicable
A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy VolunteersLupus Erythematosus, CutaneousLupus Erythematosus, SystemicLupus Erythematosus, DiscoidHealthy
NCT02034344Janssen Research & Development, LLC77
Recruiting
Not Applicable
Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy VolunteersHealthy SubjectHematologic and Lymphocytic DisorderHematopoietic and Lymphoid Cell NeoplasmImmune System DisorderMalignant Neoplasm
NCT03207854University of Southern California500